by Julienne Brabet & Mustafa F. Roustem Gareyev David has several funds of hedge funds under management. Compared with orthosteric ligands. Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. J. Bertrand is a